Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...

The gene editing company CRISPR Therapeutics surprisingly struck a deal with China-based biotech Sirius Therapeutics to ...

Senate Democrats grilled Kennedy on Tuesday over gaps in his budget and funding cuts that have halted or eliminated key ...

Under the program that was first announced by President Trump last week, the US would target prices based on benchmarks from ...

Reperio Health adds telehealth to at-home testing, raises $14M led by Caduceus Capital Partners to expand services beyond ...

Biotech execs express concerns over FDA changes, NIH cuts, and Trump's tariffs. Industry confidence low amid poor funding ...

Pfizer is dishing out $1.25 billion upfront and up to $4.8 billion in milestone payments to Shenyang-based 3SBio for the ...

Intellia's CRISPR therapy nexiguran ziclumeran maintained reductions in the levels of a misfolded protein in the nerves of ...

Prime Medicine announced Monday morning what it called 'breakthrough' clinical results from the first patient who received ...

Regeneron has a long history with its gene-sequencing efforts, which likely provides some hints as to why the biotech saw the ...

Apnimed's oral drug met the efficacy bar in the first of two Phase 3 studies in obstructive sleep apnea, the biotech said ...

CellCentric raises $120M Series C for p300/CBP inhibitor inobrodib in multiple myeloma, plans Phase 2/3 trial for accelerated ...